{"id":19294,"date":"2022-04-29T07:59:28","date_gmt":"2022-04-29T14:59:28","guid":{"rendered":"https:\/\/marketdepth.com\/?p=19294"},"modified":"2022-04-29T07:59:30","modified_gmt":"2022-04-29T14:59:30","slug":"zymeworks-confirms-acquisition-proposal-from-all-blue-falcons","status":"publish","type":"post","link":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/","title":{"rendered":"Zymeworks Confirms Acquisition Proposal from All Blue Falcons"},"content":{"rendered":"\n<p><strong>Zymeworks Inc. (NYSE: ZYME) <\/strong><a href=\"https:\/\/www.businesswire.com\/news\/home\/20220428006375\/en\/\">confirmed <\/a>yesterday evening that it had received an unsolicited, non-binding proposal from All Blue Falcons FZE and its affiliates to purchase the Company for $10.50 per share in cash.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Shares Surge Premarket<\/h5>\n\n\n\n<p>Shares of Zymeworks Inc. (NYSE: ZYME) surged over 44% during the premarket trading session following the announcement.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Clinical-Stage Biopharmaceutical<\/h5>\n\n\n\n<p>Zymeworks is a clinical-stage biopharmaceutical company focused on next-generation multifunctional biotherapeutics, and the company\u2019s board of directors will now begin to carefully review the proposal to determine the company\u2019s course of action, though no formal offer has been made by ABF.\u00a0<\/p>\n\n\n\n<p>Kingsdale Advisors is acting as strategic shareholder and communications advisor to Zymeworks. Furthermore, Blake, Cassels &amp; Graydon LLP and Wilson Sonsini Goodrich &amp; Rosati are acting as counsel to the Company.<\/p>\n","protected":false},"excerpt":{"rendered":"Zymeworks Inc. (NYSE: ZYME) confirmed yesterday evening that it had received an unsolicited, non-binding proposal from All Blue Falcons FZE and its affiliates to purchase the Company for $10.50 per share in cash. Shares Surge Premarket Shares of Zymeworks Inc. (NYSE: ZYME) surged over 44% during the premarket trading session following the announcement. Clinical-Stage Biopharmaceutical&#8230; <a class=\"view-article\" href=\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\">View Article<\/a>","protected":false},"author":3,"featured_media":18965,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":0,"footnotes":""},"categories":[9,17,8,11,16],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Zymeworks Confirms Acquisition Proposal from All Blue Falcons - MarketDepth<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zymeworks Confirms Acquisition Proposal from All Blue Falcons - MarketDepth\" \/>\n<meta property=\"og:description\" content=\"Zymeworks Inc. (NYSE: ZYME) confirmed yesterday evening that it had received an unsolicited, non-binding proposal from All Blue Falcons FZE and its affiliates to purchase the Company for $10.50 per share in cash. Shares Surge Premarket Shares of Zymeworks Inc. (NYSE: ZYME) surged over 44% during the premarket trading session following the announcement. Clinical-Stage Biopharmaceutical... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\" \/>\n<meta property=\"og:site_name\" content=\"MarketDepth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/marketdepthnews\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-29T14:59:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-29T14:59:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/marketdepth.com\/wp-content\/uploads\/2022\/03\/CancerResearch-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1347\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MarketDepth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:site\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MarketDepth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\"},\"author\":{\"name\":\"MarketDepth\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\"},\"headline\":\"Zymeworks Confirms Acquisition Proposal from All Blue Falcons\",\"datePublished\":\"2022-04-29T14:59:28+00:00\",\"dateModified\":\"2022-04-29T14:59:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\"},\"wordCount\":135,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"articleSection\":[\"Biotechnology\",\"Headlines\",\"Healthcare\",\"Investing\",\"What's Hot\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\",\"url\":\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\",\"name\":\"Zymeworks Confirms Acquisition Proposal from All Blue Falcons - MarketDepth\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/#website\"},\"datePublished\":\"2022-04-29T14:59:28+00:00\",\"dateModified\":\"2022-04-29T14:59:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/marketdepth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zymeworks Confirms Acquisition Proposal from All Blue Falcons\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/marketdepth.com\/#website\",\"url\":\"https:\/\/marketdepth.com\/\",\"name\":\"MarketDepth\",\"description\":\"Stock Market News &amp; Headlines\",\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/marketdepth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/marketdepth.com\/#organization\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"contentUrl\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"MarketDepth\"},\"image\":{\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/marketdepthnews\",\"https:\/\/twitter.com\/MarketDepthNews\",\"https:\/\/www.instagram.com\/marketdepth\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/author\/3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zymeworks Confirms Acquisition Proposal from All Blue Falcons - MarketDepth","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/","og_locale":"en_US","og_type":"article","og_title":"Zymeworks Confirms Acquisition Proposal from All Blue Falcons - MarketDepth","og_description":"Zymeworks Inc. (NYSE: ZYME) confirmed yesterday evening that it had received an unsolicited, non-binding proposal from All Blue Falcons FZE and its affiliates to purchase the Company for $10.50 per share in cash. Shares Surge Premarket Shares of Zymeworks Inc. (NYSE: ZYME) surged over 44% during the premarket trading session following the announcement. Clinical-Stage Biopharmaceutical... View Article","og_url":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/","og_site_name":"MarketDepth","article_publisher":"https:\/\/www.facebook.com\/marketdepthnews","article_published_time":"2022-04-29T14:59:28+00:00","article_modified_time":"2022-04-29T14:59:30+00:00","og_image":[{"width":1920,"height":1347,"url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2022\/03\/CancerResearch-1.jpg","type":"image\/jpeg"}],"author":"MarketDepth","twitter_card":"summary_large_image","twitter_creator":"@MarketDepthNews","twitter_site":"@MarketDepthNews","twitter_misc":{"Written by":"MarketDepth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#article","isPartOf":{"@id":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/"},"author":{"name":"MarketDepth","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69"},"headline":"Zymeworks Confirms Acquisition Proposal from All Blue Falcons","datePublished":"2022-04-29T14:59:28+00:00","dateModified":"2022-04-29T14:59:30+00:00","mainEntityOfPage":{"@id":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/"},"wordCount":135,"commentCount":0,"publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"articleSection":["Biotechnology","Headlines","Healthcare","Investing","What's Hot"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/","url":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/","name":"Zymeworks Confirms Acquisition Proposal from All Blue Falcons - MarketDepth","isPartOf":{"@id":"https:\/\/marketdepth.com\/#website"},"datePublished":"2022-04-29T14:59:28+00:00","dateModified":"2022-04-29T14:59:30+00:00","breadcrumb":{"@id":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/marketdepth.com\/zymeworks-confirms-acquisition-proposal-from-all-blue-falcons\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/marketdepth.com\/"},{"@type":"ListItem","position":2,"name":"Zymeworks Confirms Acquisition Proposal from All Blue Falcons"}]},{"@type":"WebSite","@id":"https:\/\/marketdepth.com\/#website","url":"https:\/\/marketdepth.com\/","name":"MarketDepth","description":"Stock Market News &amp; Headlines","publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/marketdepth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/marketdepth.com\/#organization","name":"MarketDepth","url":"https:\/\/marketdepth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/","url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","contentUrl":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","width":1500,"height":1000,"caption":"MarketDepth"},"image":{"@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/marketdepthnews","https:\/\/twitter.com\/MarketDepthNews","https:\/\/www.instagram.com\/marketdepth\/"]},{"@type":"Person","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69","name":"MarketDepth","url":"https:\/\/marketdepth.com\/author\/3\/"}]}},"_links":{"self":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19294"}],"collection":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/comments?post=19294"}],"version-history":[{"count":1,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19294\/revisions"}],"predecessor-version":[{"id":19295,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19294\/revisions\/19295"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media\/18965"}],"wp:attachment":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media?parent=19294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/categories?post=19294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/tags?post=19294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}